KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Restructuring Costs: 2017-2023

Historic Restructuring Costs for Elanco Animal Health (ELAN) over the last 5 years, with Jun 2023 value amounting to $35.0 million.

  • Elanco Animal Health's Restructuring Costs fell 59.30% to $35.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $126.0 million, marking a year-over-year decrease of 64.31%. This contributed to the annual value of $183.0 million for FY2022, which is 71.14% down from last year.
  • Elanco Animal Health's Restructuring Costs amounted to $35.0 million in Q2 2023, which was down 12.50% from $40.0 million recorded in Q1 2023.
  • Elanco Animal Health's 5-year Restructuring Costs high stood at $305.0 million for Q2 2021, and its period low was $24.9 million during Q1 2019.
  • In the last 3 years, Elanco Animal Health's Restructuring Costs had a median value of $63.0 million in 2022 and averaged $89.2 million.
  • As far as peak fluctuations go, Elanco Animal Health's Restructuring Costs skyrocketed by 937.50% in 2019, and later plummeted by 78.45% in 2022.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Restructuring Costs stood at $51.6 million in 2019, then soared by 224.22% to $167.3 million in 2020, then tumbled by 30.66% to $116.0 million in 2021, then plummeted by 78.45% to $25.0 million in 2022, then tumbled by 59.30% to $35.0 million in 2023.
  • Its last three reported values are $35.0 million in Q2 2023, $40.0 million for Q1 2023, and $25.0 million during Q4 2022.